Firm became aware of software issues related to most recent firmware update which could result in loss of patient tissue.
Source facts
Action
On January 30, 2025, the firm notified customers through Email of the recall.
Customers were provided with immediate actions to take to mitigate the risk of damaging the tissue sample. Among the firm's recommendations was to have a backup instrument if available. The firm's Service organization will contact customers in the coming weeks to organize the upgrade of affected instruments.
Initiated
2025-01-30
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution in the states of Idaho and Ohio. The countries of France, Australia, Belgium, China, Germany, Spain, UK, Hong Kong, Ireland, Italy, Japan, Netherlands, Norway, Poland, Singapore.
Recall number
Z-1247-2025
Recall status
Open, Classified
CDRH record ID
212369
FDA classified
2025-02-27
Recall event number
96220
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.